Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform

The brief

Carlsmed, a US-based medical technology company, is targeting growth in its spine-surgery platform. The company's strategy is driven by clinical data, reimbursement changes and a planned cervical product launch. Carlsmed's personalized spine-surgery platform is expected to benefit from these factors. A recent virtual event with Bank of America highlighted the company's growth prospects. The company's CEO, Mik, discussed the potential drivers of growth.

Auto-summarised from the full article